Abstract
Background
Lifestyle modifications and advances in surgical and endovascular techniques for treating unruptured intracranial aneurysm (UIA) have vastly evolved over the last few decades and may have reduced the incidence of aneurysmal subarachnoid hemorrhage (aSAH). However, the actual impact of these changes on the rates and outcomes of aSAH remain unexplored. Thus, we studied national aSAH admissions and outcome trends and changes of major risk factors over time.
Methods
We queried the National Inpatient Sample between 2006 and 2018 to identify adult patients admitted and treated for UIA or ruptured aneurysm with aSAH. The Cochran–Armitage test was conducted to assess the linear trend of proportion of prevalence, inpatient mortality, hypertension, and current smoking status among aSAH admissions. Multivariable logistic regression was conducted to assess the odds of presenting with aSAH versus UIA, in addition to the odds of inpatient mortality among patients with aSAH.
Results
A total of 159,913 patients presented with UIA and 133,567 presented with aSAH. Admissions for aSAH decreased by 0.97% (p < 0.001) per year. Current smoking and hypertension were associated with higher odds of being admitted for aSAH compared with the treatment for UIA (odds ratio [OR] 1.38, 95% confidence interval [CI] 1.29–1.48; OR 1.15, 95% CI 1.08–1.22, respectively). Compared with White patients, Black patients (OR 1.32, 95% CI 1.21–1.43), Hispanic patients (OR 1.38, 95% CI 1.25–1.52), and patients of other races and/or ethnicities (OR 1.73, 95% CI 1.54–1.95) had a higher chance of presenting with aSAH. Rates of inpatient mortality among aSAH admissions showed no change over time (p = 0.21). Among patients admitted with aSAH, current smoking and hypertension showed an upward trend of 0.58% (p < 0.001) and 1.60% (p < 0.001) per year, respectively.
Conclusions
Despite a downward trend in the annual frequency of hospitalizations for aSAH, inpatient mortality rates for patients undergoing treatment of the ruptured aneurysm have remained unchanged in the United States. Smoking and hypertension are increasingly prevalent among patients with aSAH. Thus, efforts to control these modifiable risk factors must be further strengthened.
Similar content being viewed by others
References
La Pira B, Singh TD, Rabinstein AA, Lanzino G. Time trends in outcomes after aneurysmal subarachnoid hemorrhage over the past 30 years. Mayo Clin Proc. 2018;93:1786–93.
Huang H, Lai LT. Incidence and case-fatality of aneurysmal subarachnoid hemorrhage in Australia, 2008–2018. World Neurosurg. 2020;144:e438–46.
Nicholson P, O’Hare A, Power S, Looby S, Javadpour M, Thornton J, et al. Decreasing incidence of subarachnoid hemorrhage. J Neurointerv Surg. 2019;11:320–2.
Korja M, Lehto H, Juvela S, Kaprio J. Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates. Neurology. 2016;87(1118–23):1.
Etminan N, Chang H-S, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol. 2019;76:588–97.
Agency for Healthcare Research and Quality. HCUP NIS overview. Rockville. https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 11 Dec 2020.
Hoh BL, Chi Y-Y, Lawson MF, Mocco J, Barker FG. Length of stay and total hospital charges of clipping versus coiling for ruptured and unruptured adult cerebral aneurysms in the nationwide inpatient sample database 2002 to 2006. Stroke. 2010;41:337–42.
Qureshi AI, Vazquez G, Tariq N, Suri MFK, Lakshminarayan K, Lanzino G. Impact of international subarachnoid aneurysm trial results on treatment of ruptured intracranial aneurysms in the United States. J Neurosurg. 2011;114:834–41.
Dandurand C, Ke JXC, Mekary RA, Prakash S, Redekop G, Gooderham P, et al. Cannabis use and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide retrospective cohort study. J Clin Neurosci. 2020;72:98–101.
Poblete R, Zheng L, Raghavan R, Cen S, Amar A, Sanossian N, et al. Trends in ventriculostomy-associated infections and mortality in aneurysmal subarachnoid hemorrhage: data from the Nationwide Inpatient Sample. World Neurosurg. 2017;99:599–604.
Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ elixhauser comorbidity index. Med Care. 2017;55:698–705.
Washington CW, Derdeyn CP, Dacey RG Jr, Dhar R, Zipfel GJ. Analysis of subarachnoid hemorrhage using the nationwide inpatient sample: the NIS-SAH severity score and outcome measure. J Neurosurg. 2014;121:482–9.
VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the e-value. Ann Intern Med. 2017;167:268–74.
Statacorp. Stata statistical software: release 16. College Station: StataCorp LLC; 2019.
Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current cigarette smoking among adults—United States, 2005–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1205–11.
Golnari P, Nazari P, Garcia RM, Weiss H, Shaibani A, Hurley MC, et al. Volumes, outcomes, and complications after surgical versus endovascular treatment of aneurysms in the United States (1993–2015): continued evolution versus steady-state after more than 2 decades of practice. J Neurosurg. 2020;134:1–14.
Øie LR, Solheim O, Majewska P, Nordseth T, Müller TB, Carlsen SM, et al. Incidence and case fatality of aneurysmal subarachnoid hemorrhage admitted to hospital between 2008 and 2014 in Norway. Acta Neurochir. 2020;162:2251–9.
Hammer A, Steiner A, Ranaie G, Yakubov E, Erbguth F, Hammer CM, et al. Impact of comorbidities and smoking on the outcome in aneurysmal subarachnoid hemorrhage. Sci Rep. 2018;8:12335.
Sandvei MS, Mathiesen EB, Vatten LJ, Müller TB, Lindekleiv H, Ingebrigtsen T, et al. Incidence and mortality of aneurysmal subarachnoid hemorrhage in two Norwegian cohorts, 1984–2007. Neurology. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2011 [cited 2021 Mar 9];77:1833–9.
Slettebø H, Karic T, Sorteberg A. Impact of smoking on course and outcome of aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 2020;162:3117–28.
Rumalla K, Lin M, Ding L, Gaddis M, Giannotta SL, Attenello FJ, et al. Risk factors for cerebral vasospasm in aneurysmal subarachnoid hemorrhage: a population-based study of 8346 patients. World Neurosurg. 2021;145:e233–41.
Rinaldo L, Rabinstein AA, Cloft HJ, Knudsen JM, Lanzino G, Rangel Castilla L, et al. Racial and economic disparities in the access to treatment of unruptured intracranial aneurysms are persistent problems. J Neurointerv Surg. 2019;11:833–6.
Atchaneeyasakul K, Tipirneni A, Zhang T, Khandelwal P, Ambekar S, Snelling B, et al. Association of hypothyroidism with unruptured cerebral aneurysms: a case-control study. J Neurosurg. 2018;128:511–4.
Giordan E, Graffeo CS, Rabinstein AA, Brown RD, Rocca WA, Chamberlain AM, et al. Aneurysmal subarachnoid hemorrhage: long-term trends in incidence and survival in Olmsted County, Minnesota. J Neurosurg. 2020;113:878–83.
Miyares LC, Falcone GJ, Leasure A, Adeoye O, Shi F-D, Kittner SJ, et al. Race/ethnicity influences outcomes in young adults with supratentorial intracerebral hemorrhage. Neurology. 2020;94:e1271–80.
Brinjikji W, Rabinstein AA, Lanzino G, Cloft HJ. Racial and ethnic disparities in the treatment of unruptured intracranial aneurysms: a study of the Nationwide Inpatient Sample 2001–2009. Stroke. 2012;43:3200–6.
Fraser SM, Torres GL, Cai C, Choi HA, Sharrief A, Chang TR. Race is a predictor of withdrawal of life support in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2018;27:3108–14.
Johnson RW, Newby LK, Granger CB, Cook WA, Peterson ED, Echols M, et al. Differences in level of care at the end of life according to race. Am J Crit Care. 2010;19:335–43 (quiz 344).
Safford M. Intracerebral hemorrhage, racial disparities, and access to care. Circulation. 2016;134:1453–5.
Flaherty ML, Woo D, Haverbusch M, Sekar P, Khoury J, Sauerbeck L, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005;36:934–7.
Rabinstein AA. Administrative medical databases for clinical research: the good, the bad, and the ugly. Neurocrit Care. 2018;29:323–5.
Hoogmoed J, Coert BA, van den Berg R, Roos YBWEM, Horn J, Vandertop WP, et al. Early treatment decisions in poor-grade patients with subarachnoid hemorrhage. World Neurosurg. 2018;119:e568–73.
de Oliveira Manoel AL, Mansur A, Silva GS, Germans MR, Jaja BNR, Kouzmina E, et al. Functional outcome after poor-grade subarachnoid hemorrhage: a single-center study and systematic literature review. Neurocrit Care. 2016;25:338–50.
Al-Mufti F, Mayer SA, Kaur G, Bassily D, Li B, Holstein ML, et al. Neurocritical care management of poor-grade subarachnoid hemorrhage: unjustified nihilism to reasonable optimism. Neuroradiol J. 2021;34:542–51.
Havard A, Jorm LR, Lujic S. Risk adjustment for smoking identified through tobacco use diagnoses in hospital data: a validation study. PLoS ONE. 2014;9:e95029.
Steinberg A, Abella BS, Gilmore EJ, Hwang DY, Kennedy N, Lau W, et al. Frequency of withdrawal of life-sustaining therapy for perceived poor neurologic prognosis. Crit Care Explor. 2021;3:e0487.
Funding
None.
Author information
Authors and Affiliations
Contributions
WW: conception and design, acquisition of data, or analysis and interpretation of data; drafting and revising article. AAR: interpretation of data; drafting and revising article. AYA: drafting and revising article. YUY: revising article. GL: revising article. WB: revising article, supervision. AAR: revising article. The final manuscript was approved by all authors.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical Approval/Informed Consent
No institutional review board approval was required, as the data were deidentified and collected from a national database.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wahood, W., Rizvi, A.A., Alexander, A.Y. et al. Trends in Admissions and Outcomes for Treatment of Aneurysmal Subarachnoid Hemorrhage in the United States. Neurocrit Care 37, 209–218 (2022). https://doi.org/10.1007/s12028-022-01476-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-022-01476-5